Nikolaus Schultz
- Cancer Research top 0.02%
- Cancer Genomics and Diagnostics 88
- Oncology top 0.05%
- Colorectal Cancer Treatments and Studies 20
- Molecular Biology top 0.05%
- Bioinformatics and Genomic Networks 21
- Pulmonary and Respiratory Medicine top 0.05%
- Prostate Cancer Treatment and Research 21
- Lung Cancer Treatments and Mutations 19
- Gastric Cancer Management and Outcomes 17
- Pathology and Forensic Medicine top 0.1%
- Genetic factors in colorectal cancer 43
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 18
- Co-authors
- Chris SanderEthan CeramiBülent Arman AksoyAnders J. SkanderupJianjiong GaoS. Onur SumerErik LarssonUğur Doğrusöz
- Journals
- Journal of Clinical Oncology (47 papers)Cancer Research (14 papers)Clinical Cancer Research (13 papers)
- Partner nations
- United StatesUnited KingdomSweden
In The Last Decade
Nikolaus Schultz
212 papers receiving 38.7k citations
Hit Papers
Peers
Comparison fields: 5 of 174
- Cancer Research 12.8k
- Oncology 11.7k
- Molecular Biology 24.8k
- Pulmonary and Respiratory Medicine 9.9k
- Pathology and Forensic Medicine 4.2k
Countries citing papers authored by Nikolaus Schultz
This map shows the geographic impact of Nikolaus Schultz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nikolaus Schultz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nikolaus Schultz more than expected).
Fields of papers citing papers by Nikolaus Schultz
This network shows the impact of papers produced by Nikolaus Schultz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nikolaus Schultz. The network helps show where Nikolaus Schultz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nikolaus Schultz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 28 | |
| 4 | 2020 | 119 | |
| 5 | 2020 | 8 | |
| 6 | 2019 | 14 | |
| 7 | 2019 | 75 | |
| 8 | 2018 | 230 | |
| 9 | 2018 | 41 | |
| 10 | 2017 | 12 | |
| 11 | 2016 | 135 | |
| 12 | Response to MET Inhibitors in Patients with Stage IV Lung Adenocarcinomas Harboring MET Mutations Causing Exon 14 Skippingbreakdown → | 2015 | 423 |
| 13 | 2014 | 25 | |
| 14 | 2014 | 219 | |
| 15 | 2014 | 156 | |
| 16 | 2013 | 267 | |
| 17 | 2012 | 32 | |
| 18 | 2012 | 175 | |
| 19 | 2011 | 92 | |
| 20 | 2011 | 88 |
About Nikolaus Schultz
Nikolaus Schultz is a scholar working on Cancer Research, Pathology and Forensic Medicine, Oncology, Pulmonary and Respiratory Medicine and Health Informatics, having authored 228 papers that have together received 39.0k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (88 papers), Genetic factors in colorectal cancer (43 papers), Bioinformatics and Genomic Networks (21 papers), Prostate Cancer Treatment and Research (21 papers), Colorectal Cancer Treatments and Studies (20 papers), Lung Cancer Treatments and Mutations (19 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (18 papers) and Gastric Cancer Management and Outcomes (17 papers). The work is most often cited by research in Cancer Research (12.8k citations), Oncology (11.7k citations), Molecular Biology (24.8k citations), Pulmonary and Respiratory Medicine (9.9k citations) and Pathology and Forensic Medicine (4.2k citations). Nikolaus Schultz has collaborated with scholars based in United States, United Kingdom and Sweden. Frequent co-authors include Chris Sander, Ethan Cerami, Bülent Arman Aksoy, Anders J. Skanderup, Jianjiong Gao, S. Onur Sumer, Erik Larsson, Uğur Doğrusöz, Benjamin Groß and Rileen Sinha. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Clinical Cancer Research, Cancer Discovery and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.